A Wisconsin couple is alleging their son died because he couldn't afford a sudden $500 spike in his asthma medication.
GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...
Shanon and William Schmidtknecht, of Poynette, say their 22-year-old son Cole was told the cost had jumped from $66 to $539 ...
2 小时on MSN
Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma ...
EXCLUSIVE: Shanon and Bill Schmidtknecht tell Rhian Lubin of their grief for son Cole and their fight for a fairer health insurance system ...
The state’s top lawyer accused a British multinational drug company of “deceptive and unfair practices” that endangered lives and exploited American taxpayers.
Cole Schmidtknecht, 22, couldn't pay for his daily inhaler due to the “prohibitively expensive” price increase. Two weeks ...
Blue Cross Blue Shield — which covers more than 10 million Texans — intends to slash coverage for several asthma therapies injected into the bloodstream under the supervision of a physician. Many ...
Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is changing how certain asthma injections are administered.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果